Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

被引：0
|
作者：
H-M Lin
L Castillo
K L Mahon
K Chiam
B Y Lee
Q Nguyen
M J Boyer
M R Stockler
N Pavlakis
G Marx
G Mallesara
H Gurney
S J Clark
A Swarbrick
R J Daly
L G Horvath
机构：
[1] The Kinghorn Cancer Centre/Garvan Institute of Medical Research,Cancer Research Division
[2] Sydney Medical School,Department of Medical Oncology
[3] University of Sydney,undefined
[4] Pharmacogenomic Research for Individualised Medicine (PRIMe) consortium,undefined
[5] Chris O’Brien Lifehouse,undefined
[6] Royal Prince Alfred Hospital,undefined
[7] Medical Oncology,undefined
[8] Concord Repatriation General Hospital,undefined
[9] Concord,undefined
[10] Medical Oncology,undefined
[11] Royal North Shore Hospital,undefined
[12] Northern Haematology and Oncology Group,undefined
[13] Sydney Adventist Hospital,undefined
[14] Calvary Mater Newcastle Hospital,undefined
[15] Westmead Hospital,undefined
[16] St Vincent’s Clinical School,undefined
[17] Faculty of Medicine,undefined
[18] UNSW Australia,undefined
[19] Signalling Network Laboratory,undefined
[20] School of Biomedical Sciences,undefined
[21] Monash University,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
circulating microRNAs; chemotherapy; metastatic prostate cancer; biomarkers; docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2462 / 2471
页数：9
相关论文
共 50 条
  • [31] Prediction of favorable outcome in a docetaxel rechallenge setting in metastatic castration-resistant prostate cancer
    Heck, Matthias Michael
    Thalgott, Mark K.
    Retz, Margitta
    Wolf, Petra
    Maurer, Tobias
    Gschwend, Juergen
    Kuebler, Hubert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [32] Oncological Outcome of Docetaxel plus Prednisolone for the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Cho, I
    Kim, E.
    Joung, J.
    Seo, H.
    Chung, J.
    Lee, K.
    UROLOGY, 2012, 80 (03) : S271 - S272
  • [33] Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea
    Cho, In-Chang
    Joung, Jae Young
    Seo, Ho Kyung
    Chung, Jinsoo
    Park, Weon Seo
    Lee, Kang Hyun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (02) : 251 - 257
  • [34] Phospholipids as Indicators of Docetaxel-Resistant Castration-Resistant Prostate Cancer
    Ingram, Lishann M.
    Mansoura, Maryam
    Cummings, Brian S.
    FASEB JOURNAL, 2019, 33
  • [35] Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
    Mahon, K. L.
    Lin, H-M
    Castillo, L.
    Lee, B. Y.
    Lee-Ng, M.
    Chatfield, M. D.
    Chiam, K.
    Breit, S. N.
    Brown, D. A.
    Molloy, M. P.
    Marx, G. M.
    Pavlakis, N.
    Boyer, M. J.
    Stockler, M. R.
    Daly, R. J.
    Henshall, S. M.
    Horvath, G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (08) : 1340 - 1348
  • [36] Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
    K L Mahon
    H-M Lin
    L Castillo
    B Y Lee
    M Lee-Ng
    M D Chatfield
    K Chiam
    S N Breit
    D A Brown
    M P Molloy
    G M Marx
    N Pavlakis
    M J Boyer
    M R Stockler
    R J Daly
    S M Henshall
    L G Horvath
    British Journal of Cancer, 2015, 112 : 1340 - 1348
  • [37] Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC).
    Mahon, K. L.
    Chatfield, M. D.
    Lee-Ng, M.
    Breit, S. N.
    Brown, D. A.
    Molloy, M. P.
    Marx, G. M.
    Pavlakis, N.
    Boyer, M. J.
    Stockler, M. R.
    Wykes, R.
    Henshall, S. M.
    Sutherland, R. L.
    Horvath, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
    Marin-Aguilera, Mercedes
    Codony-Servat, Jordi
    Kalko, Susana G.
    Fernandez, Pedro L.
    Bermudo, Raquel
    Buxo, Elvira
    Jose Ribal, Maria
    Gascon, Pedro
    Mellado, Begona
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 329 - 339
  • [39] Retreatment with docetaxel in metastatic castration-resistant prostate cancer (CRPC).
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] γ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer
    Onishi, Kenta
    Miyake, Makito
    Hori, Shunta
    Onishi, Sayuri
    Iida, Kota
    Morizawa, Yosuke
    Tatsumi, Yoshihiro
    Nakai, Yasushi
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    ONCOLOGY LETTERS, 2020, 19 (03) : 2306 - 2316
12345